Resmed Inc. buy JPMorgan Chase & Co.
Start price
31.01.25
/
50%
€233.00
Target price
31.01.26
€274.39
Performance (%)
-8.03%
End price
01.02.26
€214.30
Summary
This prediction ended on 01.02.26 with a price of €214.30. With a performance of -8.03%, the BUY prediction for Resmed Inc. by JPMorgan_Chase___Co_ closed slightly in the red. JPMorgan_Chase___Co_ has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €0.51 are taken into consideration when calculating the performance. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 0.412% | 0.412% | 3.803% |
| iShares Core DAX® | 2.554% | -0.112% | 14.995% |
| iShares Nasdaq 100 | 2.742% | -0.470% | 30.954% |
| iShares Nikkei 225® | 6.584% | 3.221% | 49.697% |
| iShares S&P 500 | 1.930% | -0.519% | 24.883% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at JPMorgan Chase & Co. from $270.00 to $286.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten